Viveve Medical Statistics
Viveve Medical (VIVE) Stock Statistics & Valuation Metrics
Total Valuation
Viveve Medical has a market cap or net worth of $2,145.00. The enterprise value is $7.36M.
- Market Cap
- $2,145.00
- Enterprise Value
- $7.36M
Share Statistics
Viveve Medical has 10,723,857 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 10,723,857
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
Viveve Medical’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -99.76%.
- Return on Equity (ROE)
- -1.46
- Return on Assets (ROA)
- -0.85
- Return on Invested Capital (ROIC)
- -99.76%
- Return on Capital Employed (ROCE)
- -1.01
- Revenue Per Employee
- 136.72K
- Profits Per Employee
- -468.66K
- Employee Count
- 47
- Asset Turnover
- 0.25
- Inventory Turnover
- 3.94
Valuation Ratios
The current PE Ratio of Viveve Medical is -0.00. Viveve Medical’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Viveve Medical had revenue of 6.43M and earned -22.03M in profits. Earnings per share was -2.65.
- Revenue
- 6.43M
- Gross Profit
- 620.00K
- Operating Income
- -21.55M
- Pretax Income
- -21.77M
- Net Income
- -22.03M
- EBITDA
- -19.63M
- Earnings Per Share (EPS)
- -2.65
Cash Flow
In the last 12 months, operating cash flow was -16.23M and capital expenditures -595,000, giving a free cash flow of -16.83M billion.
- Operating Cash Flow
- -16.23M
- Free Cash Flow
- -16.83M
- Free Cash Flow per Share
- -1.32
Dividends & Yields
Viveve Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -621631.70%
- Earnings Yield
- -1091556.34%
Stock Price Statistics
- Beta
- 219.71
- 52-Week Price Change
- -99.97%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Viveve Medical upcoming earnings date is ―, TBA (Not Confirmed).
- Last Earnings Date
- Nov 09, 2023
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Viveve Medical as a current ratio of 4.91, with Debt / Equity ratio of 35.50%
- Current Ratio
- 4.91
- Quick Ratio
- 4.58
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.70
- Interest Coverage Ratio
- -21.55
Taxes
In the past 12 months, Viveve Medical has paid 256.00K in taxes.
- Income Tax
- 256.00K
- Effective Tax Rate
- -0.01
Enterprise Valuation
Viveve Medical EV to EBITDA ratio is 0.70, with an EV/FCF ratio of 1.04.
- EV to Sales
- -2.15
- EV to EBITDA
- 0.70
- EV to Free Cash Flow
- 1.04
- EV to Operating Cash Flow
- 1.07
Balance Sheet
Viveve Medical has $5.91M in cash and marketable securities with $5.88M in debt, giving a net cash position of $26.00K billion.
- Cash & Marketable Securities
- $5.91M
- Total Debt
- $5.88M
- Net Cash
- $26.00K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.11
Margins
Gross margin is 9.65%, with operating margin of -335.40%, and net profit margin of -342.78%.
- Gross Margin
- 9.65%
- Operating Margin
- -335.40%
- Pretax Margin
- -338.80%
- Net Profit Margin
- -342.78%
- EBITDA Margin
- -305.51%
- EBIT Margin
- -323.23%
